Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Zost

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Nature Ecology & Evolution|December 1, 2025
Learning a viral protein's vocabularySeth J Zost
Cell|May 26, 2023
A budding new approach strengthens an important messageSeth J Zost, Robert H Carnahan
Cell Host & Microbe|September 15, 2022
A counterintuitive antibody cocktail disrupts coxsackievirusSeth J Zost, Matthew R Vogt
The Journal of Infectious Diseases|December 12, 2018
Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine ImmunogensSeth J Zost, Nicholas C Wu, Scott E Hensley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 SeasonSigrid Gouma, Seth J Zost, Kaela Parkhouse, et al.
STAR Protocols|May 17, 2022
Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escapeNaveenchandra Suryadevara, Pavlo Gilchuk, Seth J Zost, et al.
Plos Pathogens|October 24, 2017
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccineNicholas C Wu, Seth J Zost, Andrew J Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2017
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strainsSeth J Zost, Kaela Parkhouse, Megan E Gumina, et al.
Nature Medicine|January 20, 2022
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodiesLaura A VanBlargan, John M Errico, Peter J Halfmann, et al.
Mbio|April 4, 2019
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan LimitMeghan O Altman, Matthew Angel, Ivan Košík, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Nature Ecology & Evolution|December 1, 2025
Learning a viral protein's vocabularySeth J Zost
Cell|May 26, 2023
A budding new approach strengthens an important messageSeth J Zost, Robert H Carnahan
Cell Host & Microbe|September 15, 2022
A counterintuitive antibody cocktail disrupts coxsackievirusSeth J Zost, Matthew R Vogt
The Journal of Infectious Diseases|December 12, 2018
Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine ImmunogensSeth J Zost, Nicholas C Wu, Scott E Hensley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 SeasonSigrid Gouma, Seth J Zost, Kaela Parkhouse, et al.
STAR Protocols|May 17, 2022
Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escapeNaveenchandra Suryadevara, Pavlo Gilchuk, Seth J Zost, et al.
Plos Pathogens|October 24, 2017
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccineNicholas C Wu, Seth J Zost, Andrew J Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2017
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strainsSeth J Zost, Kaela Parkhouse, Megan E Gumina, et al.
Nature Medicine|January 20, 2022
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodiesLaura A VanBlargan, John M Errico, Peter J Halfmann, et al.
Mbio|April 4, 2019
Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan LimitMeghan O Altman, Matthew Angel, Ivan Košík, et al.
Pageof 5